Target intelligence / Profile preview

Whirlin (WHRN)

Target
WHRN
Molecular classification
Other (Scaffolding protein)
01

Overview

Whirlin is a large multidomain scaffolding protein essential for sensory neuron function, notably in the auditory and visual systems. It localizes to structures critical for hearing (stereocilia of hair cells in the inner ear) and vision (periciliary membrane complex in retina photoreceptors). The protein is necessary for the proper elongation and maintenance of hair cell stereocilia, as well as for the organization of protein complexes important for mechanotransduction and phototransduction. Mutations in WHRN lead to varying forms of sensorineural deafness and are a principal genetic cause of Usher syndrome type 2D, which combines congenital hearing loss with progressive retinal degeneration. Whirlin interacts with several other Usher syndrome proteins, forming a complex that is fundamental to the development and stability of sensory cellular architectures. No drugs currently target whirlin directly, and its primary clinical significance lies in genetic diagnosis and potential research into gene therapies for Usher syndrome. Whirlin/WHRN is not a receptor, enzyme, transporter, or canonical drug target but is a critical scaffolding/signaling protein in sensory cells. The principal involvement is as a disease gene rather than a pharmacological target; mutations cause hereditary deafness and Usher syndrome. While not presently a therapeutic target, it is a vital biomarker for genetic forms of deafness and syndromic vision loss.

Other names
DFNB31KIAA1526CIP98USH2DPDZD7BAutosomal recessive deafness type 31 proteinCASK-interacting protein CIP98WI
02

Biological functions

Organization and stabilization of stereocilia elongationActin cytoskeletal assemblyMaintenance of hair bundles in cochlear hair cellsMaintenance of the periciliary membrane complex in photoreceptorsComponent of the USH2 protein complex involved in sensory perception for hearing and vision
03

Disease associations

Deafness (autosomal recessive nonsyndromic deafness type 31)Usher syndrome type 2D (characterized by congenital deafness and progressive blindness)
04

Biomarkers

WHRN gene/protein mutations for the diagnosis of Usher syndrome type 2D and DFNB31-related deafness

Beyond the preview

Go deeper on Whirlin (WHRN).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Whirlin (WHRN).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call